TCAI and St. David’s Medical Center Advance Cardiac Rhythm Innovation
Austin, Texas, USA — May 22, 2026 The Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center has...
Alzheimer’s Disease artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Eli Lilly FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
Austin, Texas, USA — May 22, 2026 The Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center has...
LOS ANGELES, April 2026 Adagio Medical announced positive pivotal clinical results for its vCLAS® Ventricular Ablation System, highlighting a...
Irvine, California | April 24, 2026 Johnson & Johnson has announced the launch of the PERSIGMA randomized controlled trial...
BOSTON, April 24, 2026 Haemonetics Corporation has announced compelling new clinical data demonstrating the safety, efficacy, and superior performance...
Amsterdam, Netherlands – April 23, 2026 Philips announced the launch of its next-generation Bridge Plus Occlusion Balloon, a life-saving...
MADRID, Spain, April 2026 Corify Care has achieved a major regulatory milestone with U.S. FDA 510(k) clearance for its...
IRVINE, California, United States, April 7, 2026 Johnson & Johnson MedTech announced the European launch of VARIPULSE™ Pro, an...
BOSTON, March 30, 2026 In a significant advancement for interventional cardiology and electrophysiology procedures, Haemonetics Corporation announced that the...
Galway, Ireland | March 23, 2026 Medtronic plc has announced that the U.S. Food and Drug Administration (FDA) has...
LAGUNA HILLS, Calif., March 19, 2026 Adagio Medical Holdings, Inc. announced successful outcomes from Expanded Access Program (EAP) cases...
